[
    {
        "type": "text",
        "text": "Enantioselective Total Synthesis of (-)-Novofumigatonin ",
        "text_level": 1,
        "bbox": [
            84,
            135,
            787,
            160
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Vincent A. P.Ruf, Lukas J. Sprenger,\\* Kirill Volynskiy, Vanessa M. Kandler, Nima Nasiri, and Erick M. Carreira\\* ",
        "bbox": [
            84,
            163,
            818,
            200
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Cite This: J. Am. Chem. Soc.2025,147,31456-31462 ",
        "bbox": [
            125,
            216,
            428,
            231
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "ACCESS | ",
        "text_level": 1,
        "bbox": [
            84,
            256,
            172,
            275
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Metrics&More ",
        "bbox": [
            232,
            261,
            355,
            273
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Article Recommendations s Supporting Information ",
        "bbox": [
            449,
            260,
            632,
            273
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            708,
            261,
            873,
            273
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "ABSTRACT: We disclose the frstand enantioselectivesynthesis of novofumigatonin,an ortholactone meroterpenoid natural product featuring an unprecedented $7 / 6 / 5 / 6 / 5 / 5$ hexacyclic skeleton. On a strategic level, this was addressed by a highly convergent strategythat hinges oncoupling ofacomplex neopentylicorganolithiumreagent anda highly hindered ketone. Auniqueapproachto theortholactone-acetal was required asitis not peripheral but embedded within thecomplex carbocyclic framework.This key chalenge wasaddressed byorchestrationofacondensation cascadetrigered bythe selective generation ofanoxocarbeniumion. Temperingreactivity inthe faceof thedensely functionalized skeleton proved keyandculminated in the total synthesisof novofumigatonin.Ofnote,thisrepresents thefirststudyontheconstructionofsuchanembeddedortholactone,potentillyuseful for preparation of such motifs in the context of complex molecule synthesis. ",
        "bbox": [
            82,
            291,
            917,
            401
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "[n 2008,novofumigatonin (1）(Scheme 1） was isolated by Rank' from cultures of Aspergillus novofumigatus, a fungus ",
        "bbox": [
            84,
            430,
            481,
            460
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Scheme 1. Novofumigatonin and Key Transformations ",
        "text_level": 1,
        "bbox": [
            84,
            473,
            454,
            487
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": ".H O (-)-Novofumigatonin (1)Me>highly oxidized DMOA-meroterpenoidO 工 >unique heterocyclic structure\"Me Me >7/6/5/6/5/5 hexacyclic skeletonMe >embedded ortholactone>10 stereogenic centersKey transformations MeMeMe  \n√Complex fragment coupling H 1ORNC Me心 0 Me H OR 0 NC OH Me >….Me  \nMe、 + 心 MeLi Me Me Me  \n√Ortholactone lactone acetal formationHOO H OMe O o=! Me H OH condensation.--. orchestrated sequence Me 1 . O- H \"Me\"Me . .Me",
        "bbox": [
            84,
            492,
            477,
            795
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "found in the Galapagos Islands.23 Novofumigatonin is one of the most structurally complex and heavily oxygenated members of the 3,5-dimethylorsenillic acid (DMOA)- meroterpenoid class of secondary metabolites.4-6 The biosynthesis of 1 was elucidated through a series of CRISPR-Cas9 gene deletion and isolation experiments, leading to identification of an oxidative biosynthetic pathway to the unusual heterocyclic structure.7,8 The 7/6/5/6/5/5 hexacyclic skeleton of 1,with its unique embedded ortholactone and lactone-acetal cage，sparked our interest. Orthoesters and ortholactones are uncommon structural motifs in natural productsthrtotteeae in small-molecules. They are typically not considered robust, and they are rather acid labile.11,12 Other potentially reactive groups in 1 include an $\\alpha { , } \\beta$ -unsaturated $\\varepsilon$ -lactone and an aldehyde.Herein, we report the first and enantioselective total synthesis of novofumigatonin (1).The approach includes convergent coupling of two fragments, involving the addition of a neopentylic organolithium reagent to a highly hindered ketone (Scheme 1).A second salient feature of the strategy is the orchestration' of steps that proceed from a highly functional-group-dense hydroxy-keto-lactone-acid precursor to the dioxabicyclo[3.2.1]octane ortholactone-acetal tetracyclic core of the target. ",
        "bbox": [
            84,
            810,
            481,
            935
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            517,
            431,
            915,
            636
        ],
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Retrosynthetic analysis of 1(Scheme 2, top）commenced with dissection of the ortholactone and lactone-acetal to give hydroxy-keto-acid-y-lactone 2.In this respect,1 and 2 differ synthetically by merely one equivalent of water: $^ \\mathrm { ~ 2 ~ }  \\textbf { 1 } +$ $_ { \\mathrm { H } _ { 2 } \\mathrm { O } }$ . This simplistic analysis,however，masks the complexity involving the network of pathways and intermediates from IV to $\\mathbf { V }$ (Scheme 2,bottom） that are possible from hydroxy-ketoacid-y-lactone 2 to the dioxabicyclo[3.2.1]octane,incorporating ortholactone and lactone-acetal motifs.The assortment of functional groups, namely hydroxyl, ketone,acid and lactone, that participate in sequential condensation reactions requires a route that navigates the myriad of reactive intermediates (Scheme 2,bottom).Executing a successful strategy to the natural product requires judicious timing for the introduction of the ortholactone-acetal, as subsequent steps would need to be compatible with the labile ensemble of functionalities. ",
        "bbox": [
            517,
            637,
            915,
            830
        ],
        "page_idx": 0
    },
    {
        "type": "image",
        "img_path": "images/772bc90b2f0b3fd92926027d7e1ea178ba3b8b0ae2187dc22872a51bd3e561dd.jpg",
        "image_caption": [
            "Scheme 2. Retrosynthesis and Key Challenges "
        ],
        "image_footnote": [],
        "bbox": [
            82,
            95,
            915,
            473
        ],
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            82,
            482,
            481,
            510
        ],
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "An additional retrosynthetic consideration was the disconnection of 2 along the C9/C11-bond, leading to I and synthon II. This would be beneficial in the synthesis as it would entail convergent coupling of two approximately equallsizedfrmets(ee2).Iaein the hydroxy，keto and acid groups through the synthetic sequence prior to condensation was another critical challenge posed by II. These considerations led to selection of the olefins in III,which would be oxidatively unmasked to the requisite functional group pattern.Accordingly, the synthesis of iodide 3 as a precursor to a neopentylic organometal species and its coupling to a carvone-derived ketone were envisioned. ",
        "bbox": [
            84,
            511,
            479,
            690
        ],
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "The synthesis of iodide 3(Scheme 3,A) commenced with enantioselective Noyori reduction of ethyl 2-oxocyclopentane1-carboxylate (4） to give secondary alcohol 5 in $9 6 \\%$ yield and $9 4 \\%$ ee.i4’Frater-Seebach alkylation followed by elimination furnished olefin 6.15 Allylic oxidation was achieved by treatment of 6 with catalytic $\\mathrm { C u I } / t { \\mathrm { - B u O } } _ { 2 } \\mathrm { H } ,$ ，resulting in enone 7 ( $6 8 \\%$ yield).16 Determination of the enantiopurity of 7 indicated some erosion ( $7 9 \\%$ ee by HPLC vs $9 4 \\%$ ee for 5), which likely occurs during the Frater-Seebach alkylation step.17 Enone 7 was subjected to a sequence of reactions, consisting of conjugate addition of $\\mathbf { M e } _ { 2 } \\mathbf { C u L i }$ followed by subsequent trapping with methacrolein, giving rise to the aldol product in $4 8 \\%$ isolated yield alongside $3 0 \\%$ ofits diastereomer (see SI). Subsequent silylation of the secondary alcohol furnished 8 in $9 2 \\%$ yield. Vinyl triflate formation $\\left( \\mathrm { K N } ( \\mathrm { S i M e } _ { 3 } ) _ { 2 } \\right.$ followed by Comins’reagent）and subsequent reduction with $3 \\mathrm { \\ m o l \\% }$ $[ ( \\mathrm { d p p f } ) \\mathrm { P d C l } _ { 2 } ]$ and $\\mathrm { E t } _ { 3 } \\mathrm { S i H }$ delivered olefin 9 in $91 \\%$ and $9 7 \\%$ yield,respectively.Finally, $\\mathrm { L i A l H } _ { 4 }$ reduction and Appel iodination gave rise to iodide 3 in $7 7 \\%$ yield over two steps. ",
        "bbox": [
            84,
            691,
            481,
            942
        ],
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            517,
            482,
            914,
            510
        ],
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "Preparation of 10 started with condensation between $( R )$ $( - )$ -carvone and $\\mathrm { H C O } _ { 2 } \\mathrm { E t }$ (Scheme 3， B).18 Subsequent Michael addition of the unpurified 1,3-dicarbonyl compound with acrylonitrile furnished nitrile 11 in $3 1 \\%$ yield (two steps). After aldehyde protection as the corresponding dioxolane, enone 12 was reduced by treatment with $\\bar { \\mathrm { L i } } ( s { \\cdot } \\mathrm { B u } ) _ { 3 } \\mathrm { B H }$ Diastereoselective protonation of the ensuing enolate provided the ketone product as a 4:1 mixture of $\\mathrm { C } _ { \\alpha }$ -epimers (NMR), which were separable by silica-gel chromatography to give 10 in $78 \\%$ yield as a single isomer. ",
        "bbox": [
            518,
            510,
            915,
            650
        ],
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "We next turned our attention to the coupling of the two highly sterically hindered fragments (Scheme 3,C).Iodide 3 was subjected to metal-halogen exchange (2.2 equiv t-BuLi, $\\mathrm { E t } _ { 2 } \\mathrm { O }$ -pentane)，and the intermediate organolithium was treated with 10.This resulted in addition of the organolithium to the nitrile as a minor product and recovery of 10 as a mixture of epimers at $\\mathrm { C } _ { \\alpha }$ (d.r.2:1).We next employed lanthanide salts，which are known to preclude enolization19-21hreforeetoeasprereedwith $\\mathrm { L a C l } _ { 3 }$ 2LiCl in THF and stirred at r.t. for $1 \\ \\mathrm { ~ h ~ }$ ， Subsequently，a solution of the organolithium (2.0 equiv） was added to the ketone/ $\\mathbf { \\mathrm { ' L a C l } } _ { 3 }$ ·2LiCl mixture at $- 4 0 \\mathrm { ~  ~ { ~ \\circ ~ } ~ } _ { \\mathrm { ~ C ~ } }$ .Under these conditions， clean addition to ketone 10 was effected, furnishing $3 ^ { \\circ }$ -alcohol13 ( $7 1 \\%$ yield, single diastereomer). ",
        "bbox": [
            517,
            651,
            914,
            845
        ],
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "Ozonolysis of 13 followed by reductive workup gave rise to hemiacetal 14 as a mixture of diastereomers.Ley-Griffith oxidation furnished lactone-acetal 15 in $4 4 \\%$ yield over two steps as a single diastereomer. Further oxidation of the acyloxyacetal 15 was necessary to match the oxidation pattern found in 1. Conditions were required to effect saponification of the $\\delta$ -lactone followed by oxidation. We found that treatment of 15 with 2 equiv of a $1 ~ \\textbf { M }$ solution of ( $n \\mathrm { - }$ $\\mathrm { P r } ) _ { 4 } \\mathrm { N O H }$ in water followed by $\\operatorname { P h I } ( \\operatorname { O A c } ) _ { 2 }$ and $\\mathrm { R u C l } _ { 3 }$ ·hydrate afforded 16, which was used without purification.22 Desilylation with HF·pyridine gave hemiacetal 17( $3 8 \\%$ two steps). ",
        "bbox": [
            518,
            846,
            914,
            942
        ],
        "page_idx": 1
    },
    {
        "type": "image",
        "img_path": "images/3d6dcc06b063d4ad37da96ea22ea165e69f5642d5527c580d26c6b35d789096b.jpg",
        "image_caption": [
            ";cheme 3. Building Block Synthesis, Fragment Coupling,and Initial Ortholactone Formation Reactiona ",
            "@Reagents and conditions: (a) $\\mathrm { H } _ { 2 }$ $1 0 0 \\ \\mathrm { a t m } ,$ ， $[ ( \\mathrm { c y m e n e } ) \\mathrm { R u C l } _ { 2 } ] _ { 2 }$ $\\left( 0 . 2 5 ~ \\mathrm { m o l \\% } \\right)$ ， (R)-BINAP $( 0 . 6 ~ \\mathrm { m o l \\% }$ ), $\\mathrm { C H } _ { 2 } \\mathrm { C l } _ { 2 }$ $6 0 ~ ^ { \\circ } \\mathrm { C }$ $9 6 \\%$ $9 4 \\%$ ee; (b) LiN(i$\\mathrm { P r } ) _ { 2 } ,$ THF, $- 5 0$ to $- 1 0 ~ ^ { \\circ } \\mathrm { C }$ ,then MeI, THF, $^ { - 7 8 }$ to $- 1 0 \\ ^ { \\circ } \\mathrm { C } ,$ $8 6 \\%$ ；(c) $\\mathrm { P O C l } _ { 3 } ,$ py, 0 to $5 0 ~ ^ { \\circ } \\mathrm { C } ,$ $6 6 \\%$ ；(d)CuI( $1 0 \\mathrm { \\ m o l } \\%$ $t { \\cdot } \\mathrm { B u O } _ { 2 } \\mathrm { H } ,$ ${ \\mathrm { N a H C O } } _ { 3 } ,$ MeCN, $4 0 \\ ^ { \\circ } \\mathrm { C } ,$ $6 8 \\%$ $7 9 \\%$ ee; (e) $\\mathrm { C u I }$ MeLi, $\\mathrm { E t } _ { 2 } \\mathrm { O } _ { \\cdot }$ $0 ~ ^ { \\circ } C ,$ then 7, $0 ~ ^ { \\circ } C ,$ then methacrolein, THF, $^ { - 7 8 }$ t $- 5 0 ~ ^ { \\circ } \\mathrm { C } , 4 8 \\%$ （f） $t { \\mathrm { - B u M e } } _ { 2 } { \\mathrm { S i O T f } }$ 26 lutidine, $\\mathrm { C H } _ { 2 } \\mathrm { C l } _ { 2 }$ $0 ^ { \\circ } \\mathrm { C } , 9 2 \\%$ （g） ${ \\displaystyle \\mathrm { K N } ( \\mathrm { S i M e } _ { 3 } ) _ { 2 } } ,$ THF, $- 7 8 ^ { \\circ } \\mathrm { C } ,$ then Comins' reagent, $- 7 8 ~ ^ { \\circ } \\mathrm { C }$ $9 1 \\%$ （h） $[ ( \\mathrm { d p p f } ) \\mathrm { P d C l } _ { 2 } ]$ $\\left( 3 . 0 \\mathrm { \\ m o l \\% } \\right)$ ） $\\mathrm { E t } _ { 3 } \\mathrm { S i H }$ ,DMF, $6 0 ~ ^ { \\circ } \\mathrm { C } ,$ $9 7 \\%$ i $\\mathrm { L i A l H } _ { 4 } ,$ $\\mathrm { E t } _ { 2 } \\mathrm { O }$ $0 \\ ^ { \\circ } \\mathrm { C } ,$ $9 0 \\%$ $\\mathrm { P h } _ { 3 } \\mathrm { P }$ ,imidazole, $\\mathrm { I } _ { 2 } ,$ THF, $0 ~ ^ { \\circ } \\mathrm { C }$ to r.t, $8 6 \\%$ ；(k)NaH, $\\mathrm { H C O } _ { 2 } \\mathrm { E t } ,$ EtOH( $1 0 \\mathrm { \\ m o l } \\%$ $\\mathrm { E t } _ { 2 } \\mathrm { O }$ (1) acrylonitrile, DBU $2 0 \\mathrm { m o l } \\%$ ,DMF, $6 0 ~ ^ { \\circ } \\mathrm { C } ,$ $3 1 \\%$ over two steps; $\\mathrm { ( m ) }$ $( \\mathrm { C H } _ { 2 } \\mathrm { O H } ) _ { 2 } ,$ $\\mathrm { H C } ( \\mathrm { O M e } ) _ { 3 } ,$ $p$ $\\mathrm { - T s O H { \\cdot } H _ { 2 } O }$ $1 0 \\mathrm { m o l } \\% )$ , PhMe, $5 0 ~ ^ { \\circ } \\mathrm { C } ,$ $6 4 \\%$ （n） $\\operatorname { L i } ( s \\mathbf { - B u } ) _ { 3 } \\operatorname { B H } _ { \\mathrm { \\lambda } }$ THF, $- 7 8 ^ { \\circ } \\mathrm { C } ,$ 10 $( 7 8 \\% )$ ，epi-10 $( 2 0 \\% )$ ; (o) t-BuLi,3 (2.0equiv), $\\mathrm { E t } _ { 2 } \\mathrm { O } \\cdot$ -pentane (4:3), $- 7 8 ~ ^ { \\circ } \\mathrm { C }$ to r.t., then 10, $\\mathrm { L a C l } _ { 3 }$ -2LiCl THF $- 4 0 \\ ^ { \\circ } \\mathrm { C } , 7 1 \\%$ (p) $\\mathrm { O } _ { 3 } , \\mathrm { C H } _ { 2 } \\mathrm { C l } _ { 2 } \\mathrm { - M e O H - p y }$ (3:3:1), $- 7 8 \\ ^ { \\circ } \\mathrm { C } ,$ then $\\mathbf { M e } _ { 2 } S _ { i }$ $- 7 8 ~ ^ { \\circ } \\mathrm { C }$ to r.t.; (q) $\\left( n { \\mathrm { - P r } } \\right) _ { 4 } { \\mathrm { N R u O } } _ { 4 }$ $2 0 ~ \\mathrm { m o l \\% } )$ ,NMO, $\\mathrm { C H } _ { 2 } \\mathrm { C l } _ { 2 } { \\mathrm { - M e C N } }$ (2:1), $4 4 \\%$ over two steps; (r) $( n { \\mathrm { - } } \\mathrm { P r } ) _ { 4 } \\mathrm { N O H } ,$ $_ \\mathrm { M e C N - H _ { 2 } O }$ (7:1)，, then $\\operatorname { P h I } ( \\operatorname { O A c } ) _ { 2 }$ ${ \\mathrm { R u C l } } _ { 3 } { \\cdot } x { \\mathrm { H } } _ { 2 } { \\mathrm { O } }$ $2 0 ~ \\mathrm { m o l \\% } )$ ； (s)HF·py， $\\mathrm { T H F { - } p y { - } H _ { 2 } O }$ (10:2:1), $5 0 ~ ^ { \\circ } \\mathrm { C } ,$ then $\\mathrm { S i O } _ { 2 } ,$ $3 8 \\%$ over two steps; (t) PPTS, $\\mathrm { M e C } ( \\mathrm { O E t } ) _ { 3 } ,$ $6 \\%$ $\\mathrm { D B U } = 1 , 8$ -diazabicyclo[5.4.0]undec-7-ene. $\\mathrm { N M O } = N$ methyl morpholine $. N .$ oxide. $\\mathrm { P P T S } =$ pyridinium $p$ -toluenesulfonate. "
        ],
        "image_footnote": [],
        "bbox": [
            121,
            96,
            876,
            712
        ],
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            82,
            868,
            481,
            942
        ],
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "We initially examined the simplest approach to the dioxabicyclo[3.2.1]octane cage,namely, treatment of 17 with various acids (e.g, $p { \\cdot }$ TsOH， PPTS, $\\mathrm { S c ( O T f ) _ { 3 } , ~ H C O _ { 2 } H ) }$ to promote condensation with formation of ortholactone 18. Despite considerable experimentation，we were unable to ",
        "bbox": [
            518,
            868,
            915,
            942
        ],
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "Scheme 4.Revised Ortholactone Formation ",
        "text_level": 1,
        "bbox": [
            84,
            73,
            382,
            86
        ],
        "page_idx": 3
    },
    {
        "type": "image",
        "img_path": "images/952c83e863c091213e35da20144d4162abb0ac30425aaefb37a48f6f1f369577.jpg",
        "image_caption": [],
        "image_footnote": [],
        "bbox": [
            100,
            95,
            901,
            316
        ],
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "detect its formation, instead reisolating starting material or a complex mixture of multiple unidentified products (see SI). In a leading experiment, treatment of 17 with $\\mathrm { M e C ( O E t ) _ { 3 } / P P T S }$ led to the formation of 18,albeit in $6 \\%$ yield. The generation of a large number of reactive intermediates from 17 by uncontrolled protonation may promote decomposition or unproductive pathways.23 ",
        "bbox": [
            84,
            332,
            479,
            431
        ],
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "As an alternative to uncontrolled activation modes by Bronsted or Lewis acids,we pursued strategies achieving siteand chemoselective activation.Analyzing the various potential cationic intermediates and the network of pathways interconnecting them，we focused on oxocarbenium ion 19 (Scheme 4). Cation 19 bears analogy to oxocarbenium ions generated in glycosylation methods,which prescribe activatableleavinggrous2sUtlzationofsuch grousiour setting would need to meet three criteria: site-selective installation,stability through subsequent synthetic steps,and chemoselective activation. With these considerations， we chose to incorporate a thioacetal, as shown for 20.26-28 Thioacetal activation would enable a sequence of steps: ${ \\bf 2 0 } $ $1 9  2 1  2 2$ .The initially formed cation 19 would be poised to undergo capture by the spiro-fused lactone, ultimately resulting in attack by the $2 ^ { \\circ }$ -alcohol to give 22. ",
        "bbox": [
            84,
            433,
            479,
            657
        ],
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "Subjecting carboxylic acid 16 to $\\mathrm { P h } _ { 2 } \\mathrm { S } _ { 2 } / \\mathrm { M e } _ { 3 } \\mathrm { P }$ resulted in thioester 23 in $6 8 \\%$ yield over two steps from 15 (Scheme 5). After considerable experimentation, we found that treatment of 23 with $\\mathrm { K N } ( \\mathrm { S i M e } _ { 3 } \\bar { ) } _ { 2 }$ (10 equiv)/PhSH (20 equiv) in THF over 40 h led to formation of thioacetal 24 as an inconsequential mixture of diastereomers $( 4 4 \\% )$ d.r. 1.5:1) alongside recovered 23 $( 1 7 \\% )$ . We noted that reaction time, base,and stoichiometry of the latter and PhSH were crucial for formation of 24 and minimization of side products (see SI).29,30 Next,addition of MeLi to 24 mediated by $\\mathrm { L a C l } _ { 3 }$ 2LiCl gave the corresponding $3 ^ { \\circ }$ -alcohol in $8 8 \\%$ yield.19 Deprotection of the $2 ^ { \\circ }$ -alcohol with $\\left( n { \\cdot } \\mathrm { B u } \\right) _ { 4 } \\mathrm { N F }$ provided diol 25 ( $8 6 \\%$ yield)，setting the stage for the sulfur-mediated ortholactone formation cascade. ",
        "bbox": [
            84,
            660,
            479,
            856
        ],
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "In initial experiments,a variety of thiophilic activators ( $\\mathrm { \\Delta N _ { - } }$ bromosuccinimide, $\\operatorname { B r } _ { 2 } ,$ Selectfluor，PhSCl，dimethyl(methylthio)sulfonium trifluoromethanesulfonate, ${ \\bf A g P F } _ { 6 }$ and $\\mathrm { A g B F _ { 4 } , }$ see SI） were screened. Under optimized conditions, the use of $N$ -bromosuccinimide with 2,6-di-tert-butyl-4- methylpyridine (DTBMP） converted 25 to ortholactone 26 in $3 7 \\%$ yield.With the critical ortholactone/lactone-acetal cage assembled, we proceeded to complete the synthesis of 1. ",
        "bbox": [
            84,
            858,
            479,
            942
        ],
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            518,
            332,
            914,
            361
        ],
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "The sequence involving the final steps commenced with manipulation of the nitrile in 26.Heating of 26 with GhaffarParkins catalyst $\\mathrm { \\langle [ P t H ( M e _ { 2 } P O H ) ( ( M e _ { 2 } P O ) _ { 2 } H ) ] } \\mathrm { \\rangle }$ in aqueous EtOH led to amide 27 in $9 5 \\%$ yield.3132It wasof some concern to us that the conditions typically employed for amide activation would not be compatible with the ortholactone $\\left( \\mathrm { H } ^ { + } \\right)$ or bicyclic $\\gamma$ lactone (alkaline).33 As such, we turned our attention to oxidations. Recently, Bao and Wan reported the formation of esters from primary amides, involving the use of 2 equiv alcohol， trichloroisocyanuric acid (TCCA） and LiOBz in cyclohexane.34 Under modified conditions,we found that treatment of 27 with TCCA in toluene (r.t. to $6 0 ~ ^ { \\circ } \\mathrm { C }$ ）afforded lactone 28 in $6 1 \\%$ yield. Desaturation of 28 using $( \\mathrm { P h S e O } ) _ { 2 } \\mathrm { O }$ afforded $\\alpha { , } \\beta$ -unsaturated ε-lactone 29 (68%).35 ",
        "bbox": [
            518,
            362,
            914,
            572
        ],
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "In the original isolation procedure,novofumigatonin (1) was extracted with an $\\mathrm { E t O A c / H C O _ { 2 } H }$ mixture.1This suggested to us that 1 might be sufficiently stable to acid to effect selective dioxolane deprotection. Treatment of 29 with $\\mathrm { H C O } _ { 2 } \\mathrm { H }$ led to formation of 30 accompanied by traces of 1. This leading result compelled us to investigate other conditions that are known to effect chemoselective acetal deprotection in the presence of other acid-labile functional groups and thereby minimize formation of 30 (see SI). Under optimized conditions,treatment of 29 with DDQ in wet MeCN furnished novofumigatonin (1） in $5 0 \\%$ yield，thus completing the first total synthesis of the natural product.36,37 The analytical data ( $\\mathrm { ^ { \\circ } H N M R } ,$ $^ { 1 3 } \\mathrm { C }$ NMR, HRMS, IR, $[ \\alpha ] _ { \\mathrm { D } } )$ of synthetic 1 are in agreement with data reported for the isolated material.1,7 ",
        "bbox": [
            517,
            575,
            914,
            786
        ],
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "In conclusion,we have achieved the first and enantioselective total synthesis of novofumigatonin (1).A powerful anionic fragment coupling followed by a series of oxidative transformations led to the rapid construction of the highly oxygenated backbone of 1.Access to the uniquely complex heterocyclic cage of the natural product was enabled by a cascade of reactions hinging on a novel， sulfur-mediated ortholactone formation. We present a synthetic strategy to this class of oxygenated DMOA-meroterpenoids，exemplified by the synthesis of one of its most highly oxidized members isolated to date.This study serves as an entry point for the synthesis of_other complex natural products bearing embedded ortholactones. ",
        "bbox": [
            518,
            787,
            914,
            941
        ],
        "page_idx": 3
    },
    {
        "type": "image",
        "img_path": "images/680184096f6711241699bea9e40280e1c1c8233c589377ef5173df149965fc44.jpg",
        "image_caption": [
            "Scheme 5. Completion of the Synthesis ",
            "aReagents and conditions: (a) ${ \\mathrm { P h } } _ { 2 } S _ { 2 } ,$ $\\mathrm { { \\bf M e } } _ { 3 } \\mathrm { { P } } _ { . }$ py, then 16, $6 8 \\%$ over two steps from 15; (b) ${ \\mathrm { K N } } ( { \\mathrm { S i M e } } _ { 3 } ) _ { 2 } ,$ PhSH, THF,then 23,THF, $4 4 \\%$ (d.r.1.5:1), $1 7 \\%$ recovered 23； (c) $\\mathrm { L a C l } _ { 3 }$ 2LiCl，THF，r.t.,，then MeLi, $- 7 8 ^ { \\circ } \\mathrm { C } ,$ $8 8 \\%$ ；(d) $( n { \\mathrm { - B u } } ) _ { 4 } { \\mathrm { N F } }$ ，EtOAc, $^ { - 7 8 }$ to $- 6 \\ ^ { \\circ } \\mathrm { C } ,$ $8 6 \\%$ ；(e) $N \\cdot$ bromosuccinimide (NBS)， DTBMP,4 A MS, $\\mathrm { C H } _ { 2 } \\mathrm { C l } _ { 2 }$ $3 7 \\%$ ;(f) Ghaffar-Parkinscatalyst $( 4 0 \\mathrm { \\ m o l \\% } )$ ) $\\mathrm { E t O H - H _ { 2 } O }$ (4:1)， $6 0 ~ ^ { \\circ } \\mathrm { C }$ $9 5 \\%$ $( \\mathbf { g } )$ trichloroisocyanuric acid (TCCA) $\\mathrm { L i O B z } ,$ PhMe, r.t. to 50 to $6 0 \\ ^ { \\circ } \\mathrm { C } ,$ $6 1 \\%$ ；(h) $( \\mathrm { P h S e O } ) _ { 2 } \\mathrm { O } ,$ 4 A MS, $\\mathrm { P h C l } _ { i }$ $1 4 0 ~ ^ { \\circ } \\mathrm { C }$ $6 8 \\%$ (i) $\\mathrm { H C O } _ { 2 } \\mathrm { H } { - } \\mathrm { H } _ { 2 } \\mathrm { O }$ (3:1),$4 4 \\%$ ；(j)2,3-dichloro $^ { 5 , 6 }$ dicyano-1,4-benzoquinone (DDQ), ${ \\mathrm { M e C N - H } } _ { 2 } \\mathrm { O }$ (10:1), $3 5 ~ ^ { \\circ } \\mathrm { C }$ $5 0 \\%$ ，"
        ],
        "image_footnote": [],
        "bbox": [
            107,
            93,
            876,
            693
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            82,
            777,
            482,
            805
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "ASSOCIATED CONTENT ",
        "text_level": 1,
        "bbox": [
            85,
            822,
            286,
            836
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "$\\bullet$ Supporting Information ",
        "text_level": 1,
        "bbox": [
            84,
            843,
            273,
            857
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/jacs.5c10466. ",
        "bbox": [
            82,
            860,
            481,
            887
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "Experimental procedures and characterization data for all new compounds and X-ray crystallographic data (PDF) ",
        "bbox": [
            121,
            896,
            481,
            937
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "Accession Codes ",
        "text_level": 1,
        "bbox": [
            517,
            777,
            634,
            790
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "Deposition Numbers 2452287， 2452289，and 2463553 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge via the joint Cambridge Crystallographic Data Centre (CCDC） and Fachinformationszentrum Karlsruhe Access Structures service. ",
        "bbox": [
            517,
            793,
            914,
            861
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "AUTHOR INFORMATION ",
        "text_level": 1,
        "bbox": [
            520,
            878,
            729,
            892
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "Corresponding Author ",
        "text_level": 1,
        "bbox": [
            518,
            900,
            675,
            913
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "Erick M. Carreira - ETH Zurich,Department of Chemistry and Applied Biosciences, Laboratory of Organic Chemistry, ",
        "bbox": [
            533,
            915,
            915,
            942
        ],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "8093 Zurich, Switzerland; $\\circledcirc$ orcid.org/0000-0003-1472-   \n490X; Email: carreira@ethz.ch ",
        "bbox": [
            110,
            72,
            469,
            100
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "Authors ",
        "text_level": 1,
        "bbox": [
            82,
            110,
            138,
            122
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "Vincent A. P.Ruf - ETH Zürich, Department of Chemistry and Applied Biosciences, Laboratory of Organic Chemistry, 8093 Zürich, Switzerland; $\\circledcirc$ orcid.org/0009-0004-6417- 5085   \nLukas J. Sprenger - ETH Zürich,Department of Chemistry and Applied Biosciences, Laboratory of Organic Chemistry, 8093 Zürich, Switzerland; $\\circledcirc$ orcid.org/0000-0001-7932- 8065   \nKirill Volynskiy-ETH Zürich,Department of Chemistry and Applied Biosciences, Laboratory of Organic Chemistry, 8093 Zurich, Switzerland; $\\circledcirc$ orcid.org/0009-0002-8069- 1819   \nVanessa M. Kandler -ETH Zürich,Department of Chemistry and Applied Biosciences, Laboratory of Organic Chemistry，8093 Zurich, Switzerland   \nNima Nasiri - ETH Zürich,Department of Chemistry and Applied Biosciences,Laboratory of Organic Chemistry,8093 Zurich, Switzerland; @ orcid.org/0000-0002-4719-7811 ",
        "bbox": [
            95,
            120,
            481,
            371
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "Complete contact information is available at: https://pubs.acs.0rg/10.1021/jacs.5c10466 ",
        "bbox": [
            82,
            377,
            377,
            403
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "Author Contributions ",
        "text_level": 1,
        "bbox": [
            84,
            418,
            232,
            430
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "+V.A.P.R and L.J.S. contributed equally to this work. ",
        "bbox": [
            84,
            432,
            429,
            446
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "Funding ",
        "text_level": 1,
        "bbox": [
            82,
            450,
            141,
            462
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "We thank ETH Zürich for funding of this work. L.J.S. is an awardee of the Scholarship Fund of the Swiss Chemical Industry (SSCI). ",
        "bbox": [
            82,
            463,
            479,
            505
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "Notes ",
        "text_level": 1,
        "bbox": [
            82,
            508,
            123,
            520
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "The authors declare no competing financial interest. ",
        "bbox": [
            84,
            522,
            423,
            536
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "ACKNOWLEDGMENTS ",
        "text_level": 1,
        "bbox": [
            84,
            550,
            276,
            562
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "We are grateful to Dr. Marc-Olivier Ebert，René Arnold, Rainer Frankenstein，and Stephan Burkhardt for NMR measurements and to Dr.Nils Trapp and Michael Solar for X-ray crystallographic analysis. ",
        "bbox": [
            82,
            568,
            479,
            623
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "REFERENCES ",
        "text_level": 1,
        "bbox": [
            84,
            636,
            205,
            648
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "(1）Rank, C.; Phipps,R.K.; Harris,P.; Fristrup,P.; Larsen, T.O.; Gotfredsen, C.H. Novofumigatonin,a New Orthoester Meroterpenoid from Aspergillus novofumigatus. Org. Lett. 2008,10 (3),401- 404.   \n(2） Hong, S.-B.; Seung-Joo,G.； Hyeon-Dong, S.; C,F.J.； Samson, R.A.Polyphasic taxonomy of Aspergillus fumigatus and related species.Mycologia 2005,97 (6),1316-1329.   \n(3) Samson,R.A.; Hong,S.; Peterson,S.W.;Frisvad,J. C.; Varga, J.Polyphasic taxonomy of Aspergillus section Fumigati and its teleomorph Neosartorya. Stud.Mycol.2007,S9,147-203.   \n(4) Geris,R.； Simpson,T.J. Meroterpenoids produced by fungi. Nat.Prod.Rep.2009,26 (8),1063-1094.   \n(S) Jiang,M.;Wu,Z.; Liu,L.; Chen,S.The chemistry and biology of fungal meroterpenoids (2009-2019). Org. Biomol. Chem.2021,19 (8),1644-1704.   \n(6)For selected examples of total syntheses of DMOAmeroterpenoids,see:(a） Ting,C.P.；Xu, G.； Zeng, X.；Maimone, T.J.Annulative Methods Enable a Total Synthesis of the Complex Meroterpene Berkeleyone A. J.Am. Chem. Soc.2016,138 (45), 14868-14871. (b） Elkin，M.；Szewczyk，S. M.；Scruse，A.C.; Newhouse, T.R. Total Synthesis of $( \\pm )$ -BerkeleyoneA. J.Am. Chem. Soc. 2017,139 (S),1790-1793.(c) Xu,G.; Elkin, M.; Tantilo,D.J; Newhouse，T.R.；Maimone，T.J.Traversing Biosynthetic Terretonin Meroterpenes.Angew. Chem.， Int.Ed. 2017,56 (41), 12498-12502.(d） Powers,Z.；Scharf,A.； Cheng，A.；Yang，F.; Himmelbauer,M.；Mitsuhashi, T.；Barra,L.；Taniguchi,Y.； Kikuchi, T.；Fujita，M.；Abe,I.；Porco,J.A., Jr.Biomimetic Synthesis of Meroterpenoids by Dearomatization-Driven Polycyclization. Angew. Chem.,Int.Ed. 2019,58 (45),16141-16146. (e) Zhang, Y.; Ji,Y.; Franzoni, I.; Guo, C.; Jia,H.; Hong, B.; Li, H.Enantioselective Total Synthesis of Berkeleyone A and Preaustinoids. Angew. Chem., Int.Ed. 2021,60 (27),14869-14874. (f) Yang,F.; Porco,J.A., Jr.Unified, Asymmetric Total Synthesis of the Asnovolins and Related Spiromeroterpenoids: A Fragment Coupling Approach. J. Am. Chem.Soc.2022,144 (28)，12970-12978. (g) Yang,F.; Oladokun, A.；Porco,J.A，Jr.Evolutionof a Strategy for the Unified, Asymmetric Total Syntheses_of DMOA-Derived Spiromeroterpenoids.J.OrgChem.22489(17),891108.()LiX;ang Z.；Duan，S.；Xie，Z.Total Synthesis of Berkeleyone A and Preaustinoid A through Epoxypolyene Cyclization. Angew. Chem., Int.Ed.2025,64 (4),No.e202416211. (i) Tang,F.；Zhang, Z.-C.; Song, Z.-L.; Li, Y.-H.; Zhou, Z.-H.; Chen,J-J.; Yang, Z.Asymmetric Total Synthesis of Janthinoid A. J. Am. Chem. Soc.2025,147 (6), 4731-4735.(j) Zhang,J; Luo,X; Zhang,J.; Li, C. Total Synthesis ofDMOA-Derived Meroterpenoids: Achieving Selectivity in the Synthesis of $\\left( + \\right)$ -Berkeleyacetal D and $\\left( + \\right)$ -Peniciacetal I. J. Am. Chem. Soc.2025,147 (7),5933-5942.   \n(7）Matsuda,Y.； Bai，T.； Phippen， C.B.W.； Nodvig,C.S.; Kjerbolling, I； Vesth， T. C.；Andersen， M. R；Mortensen, U.H.; Gotfredsen，C.H.；Abe，I.；Larsen，T.O．Novofumigatonin biosynthesis involves a non-heme iron-dependent endoperoxide isomerase for orthoester formation.Nat. Commun. 2018,9(1),2587. (8)Mori, T.; Zhai,R.; Ushimaru,R.; Matsuda, Y.;Abe,I.Molecular insights into the endoperoxide formation by $\\mathrm { F e } ( \\mathrm { I I } ) / \\alpha$ -KG-dependent oxygenase Nvfl. Nat.Commun. 2021,12 (1),4417.   \n(9)Liao, S.-G.； Chen,H.-D.; Yue, J.-M. Plant Orthoesters.Chem. Rev. 2009,109 (3),1092-1140.   \n(10）For selected examples of total syntheses of orthoester- and ortholactone-containing natural products，see:(a） Paquette,L.A.; Wang，T.-Z.； Sivik，M.R.Enantioselectivesynthesis of natural $( - )$ -austalide B,an unusual ortho ester metabolite produced by toxigenic cultures of Aspergillus ustus.J.Am. Chem. Soc.1994,116 (6),2665-2666. (b) Wender,P.A.; Jesudason,C.D.; Nakahira,H.; Tamura，N.；Tebbe，A. L.；Ueno,Y. The First Synthesis of a Daphnane Diterpene: The Enantiocontrolled Total Synthesis of $\\left( + \\right)$ -Resiniferatoxin.J. Am. Chem. Soc.1997,119 (52),12976-12977. (c） Nicolaou, K. C.； Mitchell,H. J.； Suzuki, H.； Rodriguez,R.M.; Baudoin,O.；Fylaktakidou,K.C.Total Synthesis of Everninomicin 13,384-1—Part 1: Synthesis of the A1B(A)C Fragment. Angew. Chem.,Int.Ed.1999,38 (22)，3334-339.(d) NicolaouK.C.; Rodriguez，R.M.；Fylaktakidou, K. C.； Suzuki, H.； Mitchell，H.J. Total Synthesis of Everninomicin 13,384-1—Part 2: Synthesis of the FGHA2 Fragment. Angew. Chem.， Int.Ed. 1999,38 (22)，3340- 3345.(e）Nicolaou，K. C.；Mitchell，H.J.；Rodriguez，R. M.; Fylaktakidou,K.C.；Suzuki， H. Total Synthesis of Everninomicin 13,384-1—Part 3: Synthesis of the DE Fragment and Completion of the Total Synthesis. Angew.Chem.,Int.Ed.1999,38 (22),3345- 3350.   \n(11）Ahmad,M.； Bergstrom，R G.； Cashen, M.J.； Kresge,A. J.; McClelland，R.A.；Powell，M.F.Ortho ester hydrolysis.The complete reaction mechanism. J. Am. Chem. Soc. 1977,99 (14), 4827-4829.   \n(12）Chiang, Y.；Kresge， A.J.； Lahti，M. O.；Weeks，D.P. Hydrolysis of ortho esters:further investigation of the factors that control the rate-determining step. J. Am.Chem. Soc.1983,105 (23), 6852-6855.   \n(13）For a review on fragment coupling in total synthesis， see: Tomanik, M.; Hsu,I. T.; Herzon,S.B.Fragment Coupling Reactions in Total Synthesis That Form Carbon-Carbon Bonds via Carbanionic or Free Radical Intermediates. Angew. Chem.， Int.Ed. 2021,60 (3). 1116-1150. (14）Kitamura，M.；Ohkuma，T.；Tokunaga，M.；Noyori，R. Dynamic kinetic resolution in BINAP—ruthenium(II） catalyzed hydrogenation of 2-substituted 3-oxo carboxylic esters.Tetrahedron: Asymmetry 1990,1 (1),1-4.   \n(15)Kuwata,K.; Hanaya,K.; Sugai, T.; Shoji, M. Chemo-enzymatic synthesis of (R)-5-hydroxymethyl-2-isopropyl-5-methylcyclopent-1- en-l-yl trifluoromethylsulfonate,a potential chiral building block for multicyclic terpenoids. Tetrahedron: Asymmetry 2017,28 (7),964- 968.   \n(16)Salvador,J.A.R.；Säe Melo,M.L.； Campos Neves,A. S. Copper-catalysed allylic oxidation of △S-steroids by t-butyl hydroperoxide. Tetrahedron Lett.1997,38 (1),119-122.   \n(17) We hypothesize that two pathways may lead to epimerization: (i) retro-aldol/aldol reaction during the Frater-Seebach alkylation; and (ii） because the diastereomers (d.r. 2O:1） were not separated follwing the Frater-Seebach alkylation， the minor diastereomer leads to the enantiomer of 6 in the subsequent elimination step. (18)Jansen,B.J. M.; Hendrikx, C. C.J.; Masalov,N.； Stork, G.A.; Meulemans,T.M.；Macaev,F.Z.；de Groot,A. Enantioselective Synthesis of Functionalised Decalones by Robinson Annulation of Substituted Cyclohexanones,Derived from $\\mathrm { R } { } \\mathrm { - } \\left( \\mathrm { - } \\right)$ -Carvone.Tetrahedron 2000,56 (14),2075-2094.   \n(19)Krasovskiy,A.; Kopp,F.;Knochel, P.Soluble Lanthanide Salts (LnCl3·2 LiCl) for the Improved Addition of Organomagnesium Reagents to Carbonyl Compounds.Angew. Chem., Int.Ed.2006,45 (3),497-500.   \n(20）Imamoto，T.； Sugiura，Y.；Takiyama，N.Organocerium reagents.Nucleophilic addition to easily enolizable ketones. Tetrahedron Lett.1984,25 (38),4233-4236.   \n(21）Dimitrov,V.; Kostova,K.；Genov,M.Anhydrous cerium(II) chloride-Efect of the_drying process on activity and effcency. Tetrahedron Lett.1996,37 (37),6787-6790.   \n(22）Nannini，L. J. Total Synthesis of Sarcophytin and Studies Towards Pavidolide B and Related Cembranoids.Doctoral Dissertation No.25429,ETH Zurich,2018.   \n(23）Examples may include elimination，retro-aldol reaction, translactonization or epimerization: Me   \nM 0 OH OH OH H   \nHO1 HO Me \".Me 三 Me \\\"Me HO Me \".Me \\ \"Me \".Me HO \\\"Me \\.e 2°-OH- double 3°-OH- retro-aldol translactonisation/ elimination elimination elimination reaction epimerisation (24）Das,R.；Mukhopadhyay,B. Chemical O-Glycosylations:An Overview. ChemistryOpen 2016,5 (5),401-433.   \n(25）For selected examples of orthoester formation from glycoside onium ions, see: (a) Zuurmond,H.M.; van der Laan, S.C.; van der Marel, G.A.; van Boom, J. H. Iodonium ion-assisted glycosylation of alkyl(aryl）1-thio-glycosides:regulation of stereoselectivity and reactivity. Carbohydr.Res.1991,215 (2),C1-C3.(b) Crich,D.; Hu, T.；Cai, F.Does Neighboring Group Participation by Non-Vicinal Esters Play a Role in Glycosylation Reactions? Effective Probes for the Detection of Bridging Intermediates.J. Org. Chem.2008,73 (22), 8942-8953.(c） Muru,K.；Cloutier，M.；Provost-Savard,A.；Di Cintio,S.; Burton, O.; Cordeil, J.; Groleau,M.-C.; Legault,J.;Déziel, E.;Gauthier, C.Total Synthesis of a Chimeric Glycolipid Bearing the Partially Acetylated Backbone of Sponge-Derived Agminoside E.J. Org. Chem.2021,86 (21), 15357-15375.   \n(26） Zhong,W.；Boons,G.-J.； Crich,D.； Bowers,A.A. Glycoside Synthesis from 1-Sulfur/Selenium-Substituted Derivatives:Sections 4.1 and 4.2.Handbook of Chemical Glycosylation 2008,261-329. (27）Lian,G.；Zhang,X.；Yu,B.Thioglycosides in Carbohydrate Research. Carbohydr.Res.2015,403,13-22.   \n(28）Nicolaou,K.C.；Seitz, S.P.；Papahatjis,D.P.A mild and general method for the synthesis of O-glycosides.J.Am. Chem. Soc. 1983,105 (8),2430-2434. ",
        "bbox": [
            82,
            655,
            481,
            941
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            517,
            81,
            915,
            940
        ],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            82,
            72,
            481,
            541
        ],
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            87,
            545,
            479,
            646
        ],
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "",
        "bbox": [
            82,
            650,
            481,
            941
        ],
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "(29）The reaction was performed on at least $2 0 \\mathrm { - m g }$ scale as the transformation was found to be capricious on smaller scale. (30)Forrelated trasfoationssee: (a)eeler，D.D.;Young D. C.;Erley,D.S.Reactions of Phthalaldehydic Acid.J. Org.Chem. 1957,22 (S),547-556. (b) Ito,K.; Miyajima,S. (Z)- and (E)-4,4- Dimethyl-5-oxo-2-pentenoic Acids and Their Derivatives.Bull.Chem. Soc.Jpn.1986,59 (3)，815-818.(c） Takahashi，M.； Sekine,N.; Fujita,T.；Watanabe,S.； Yamaguchi,K.； Sakamoto,M. Solid-State Photochemistry of o-Aroylbenzothioates: Absolute Asymmetric Phthalide Formation Involving 1,4-Aryl Migration. J.Am.Chem. Soc.1998,120 (49),12770-12776.(d) Sakulsombat,M.； Angelin, M.；Ramstrom，O．Tandem reversible addition-intramolecular lactonization for the synthesis of 3-functionalized phthalides. Tetrahedron Lett.2010,S1 (1)，75-78.(e） Kanishchev, O. S.; Lavoignat,A.;Picot, S.；Médebielle,M.; Bouillon,J.-P.New route to the 5-((arylthio-and heteroarylthio)methylene)-3-(2,2,2-trifluoroethyl)-furan-2(SH)-ones-Key intermediates in the synthesis of 4- aminoquinoline y-lactams as potent antimalarial compounds. Bioorg. Med. Chem. Lett.2013,23 (22),6167-6171. (31）Ghaffar， T.；Parkins,A.W.A new homogeneous platinum containing catalyst for the hydrolysis of nitriles. Tetrahedron Lett. 1995,36 (47), 8657-8660. (32)Ghafar,T.；Parkins,A.W.The catalytic hydration of nitriles to amides using a homogeneous platinum phosphinito catalyst. J. Mol. Catal. A: Chem. 2000,160 (2),249-261. (33) OConnor, C.Acidic and basic amide hydrolysis. Q. Rev. Chem. Soc. 1970,24 (4),553-564. (34)Wan,X.; Lin,J; Bai,J; Li,J; Wang,K;Cao,Z.; Li.;Bao X.；Wan， X. Interception of RCONCl2:late-stage hydrolysis and esterification of primary amides.Org. Chem. Front. 2024，11 (1), 183-193. (35）Barton,D.H.R.; Lester,D.J.; Ley, S.V.Dehydrogenation of steroidal ketones using benzeneseleninic anhydride. J. Chem. Soc., Chem. Commun. 1978,3,130-131. (36）Tanemura，K.； Suzuki，T.；Horaguchi， T. 2,3-Dichloro-5,6- dicyano-p-benzoquinone as a mild and efficient catalyst for the deprotection of acetals.J. Chem. Soc.， Chem. Commun. 1992，14, 979-980. (37）For a discussion on the mechanism of the DDQ-mediated acetal deprotection， see:Oku，A.；Kinugasa，M.；Kamada，T. Deprotection of Acetals and Silyl Ethers by DDQ.Is DDQ a Neutral Catalyst? Chem.Lett 1993,22 (1),165-168. ",
        "bbox": [
            515,
            71,
            915,
            602
        ],
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "NOTE ADDED AFTER ASAP PUBLICATION ",
        "text_level": 1,
        "bbox": [
            518,
            608,
            861,
            622
        ],
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "This Communication published ASAP on August 20,2025. Scheme 3 has been updated and the corrected version reposted on August 21,2025. ",
        "bbox": [
            517,
            627,
            915,
            668
        ],
        "page_idx": 6
    }
]